Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

WhiteOak Capital Pharma and Healthcare Fund · Regular ✕Edelweiss Technology Fund · Regular ✕

Growth of ₹10,000

Basics

WhiteOak Capital Pharma and Healthcare FundEdelweiss Technology Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseWhiteOakEdelweiss
NAV₹17.5790₹12.2886
NAV date20 Nov 202620 Nov 2026
History2.8 years2.7 years
Expense ratio2.7%2.4%
StarsNot ratedNot rated
Growth Score——

Returns

WhiteOak Capital Pharma and Healthcare FundEdelweiss Technology Fund
1 month+11.83%−2.35%
3 months+4.86%−3.77%
6 months+16.09%+4.86%
YTD+27.99%+0.18%
1 year+24.66%+0.68%
3 years (CAGR)——
5 years (CAGR)——
10 years (CAGR)——
Since launch+22.13%+7.77%

Risk

WhiteOak Capital Pharma and Healthcare FundEdelweiss Technology Fund
Volatility——
Downside volatility——
Sharpe——
Sortino——
Calmar——
Return / risk——
Deepest fall−15.62%−26.63%
Days to recover137484
Below its high−0.05%−5.40%

Against benchmark

WhiteOak Capital Pharma and Healthcare FundEdelweiss Technology Fund
Alpha——
Beta——
R²——
Up capture——
Down capture——
Tracking error——
Information ratio——
Treynor——

Consistency

WhiteOak Capital Pharma and Healthcare FundEdelweiss Technology Fund
Best 1-year+33.22%+16.75%
Middle 1-year+16.64%+3.50%
Worst 1-year−1.11%−6.37%
1-year periods with a loss1.4%19.3%
Middle 3-year——
Positive months——
Best day+3.87%+4.96%
Worst day−3.51%−4.10%
Worst 5% day−1.53%−1.53%
Positive days55.7%53.5%
NAVs a year247247

SIP of ₹10,000 a month

WhiteOak Capital Pharma and Healthcare FundEdelweiss Technology Fund
5-year XIRR——
5-year value——
3-year XIRR——
1-year XIRR+34.56%+6.00%

Holdings overlap i

Overlap compares the shares two funds hold, so it needs at least two of these funds with shares in a loaded monthly filing.
  • WhiteOak Capital Pharma and Healthcare Fund: no monthly portfolio filing from WhiteOak is loaded yet, so it is left out here.
  • Edelweiss Technology Fund: no monthly portfolio filing from Edelweiss is loaded yet, so it is left out here.

Search Growth